Global Patent Index - EP 1819345 A4

EP 1819345 A4 20120418 - USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASE

Title (en)

USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASE

Title (de)

VERWENDUNG VON LIPIDKONJUGATEN BEI DER BEHANDLUNG VON KRANKHEITEN

Title (fr)

UTILISATION DE CONJUGUES LIPIDIQUES DANS LE TRAITEMENT DE MALADIES

Publication

EP 1819345 A4 20120418 (EN)

Application

EP 05808267 A 20051117

Priority

  • IL 2005001225 W 20051117
  • US 98960704 A 20041117
  • US 98960604 A 20041117
  • US 2005006591 W 20050302

Abstract (en)

[origin: WO2006054304A2] This invention provides for the use of a compound comprising a lipid or phospholipid moiety bond to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof, for the preparation of a composition for treating a subject suffering from asthma, allergic rhinitis, or chronic obstructive pulmonary disease. This invention also provides for the use of a compound comprising a lipid or phospholipid moiety bond to a physiologically acceptable monomer, dimer, oligomer, or polymer, and/or a pharmaceutically acceptable salt or a pharmaceutical product thereof, for the preparation of a composition for preventing asthma, allergic rhinitis, or chronic obstructive pulmonary disease in a subject.

IPC 8 full level

A61K 31/70 (2006.01); A61K 31/728 (2006.01); A61K 31/737 (2006.01); A61K 47/48 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01)

CPC (source: EP)

A61K 31/728 (2013.01); A61K 31/737 (2013.01); A61K 47/544 (2017.07); A61K 47/61 (2017.07); A61P 1/04 (2017.12); A61P 7/00 (2017.12); A61P 11/00 (2017.12); A61P 11/02 (2017.12); A61P 11/06 (2017.12); A61P 17/00 (2017.12); A61P 25/00 (2017.12); A61P 27/02 (2017.12); A61P 31/04 (2017.12); A61P 31/12 (2017.12); A61P 37/04 (2017.12); A61P 37/08 (2017.12); A61P 43/00 (2017.12)

Citation (search report)

  • [X] US 2004087492 A1 20040506 - YEDGAR SAUL [IL], et al
  • [A] PHYLLIS DAN ET AL: "Inhibition of Type I and Type II Phospholipase A 2 by Phosphatidyl-Ethanolamine Linked to Polymeric Carriers +", BIOCHEMISTRY, vol. 37, no. 17, 1 April 1998 (1998-04-01), pages 6199 - 6204, XP055004270, ISSN: 0006-2960, DOI: 10.1021/bi972066l
  • See references of WO 2006054304A2

Citation (examination)

WO 9321211 A1 19931028 - MENARINI LAB [ES], et al

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2006054304 A2 20060526; WO 2006054304 A3 20070125; AU 2005305456 A1 20060526; AU 2005305456 B2 20110519; BR PI0516810 A 20080923; CA 2587883 A1 20060526; CN 101175499 A 20080507; CN 101175499 B 20101222; EA 012138 B1 20090828; EA 200701077 A1 20080428; EP 1819345 A2 20070822; EP 1819345 A4 20120418; IL 183227 A0 20070819; IL 212214 A0 20110630; IL 212215 A0 20110630; JP 2008520650 A 20080619; JP 2012001559 A 20120105; MX 2007005975 A 20071008

DOCDB simple family (application)

IL 2005001225 W 20051117; AU 2005305456 A 20051117; BR PI0516810 A 20051117; CA 2587883 A 20051117; CN 200580046771 A 20051117; EA 200701077 A 20051117; EP 05808267 A 20051117; IL 18322707 A 20070515; IL 21221411 A 20110407; IL 21221511 A 20110407; JP 2007542507 A 20051117; JP 2011199088 A 20110913; MX 2007005975 A 20051117